Risk factors associated with clinically relevant pericardial effusion after primary cardiac implantable electronic device implantation

被引:0
|
作者
Zhou, Yangzhi [1 ]
Haxha, Saranda [1 ,2 ]
Halili, Andrim [1 ,2 ]
Philbert, Berit T. [3 ]
Nielsen, Olav W. [1 ]
Sajadieh, Ahmad [1 ]
Koeber, Lars [3 ]
Gislason, Gunnar H. [4 ]
Torp-Pedersen, Christian
Bang, Casper N. [1 ]
机构
[1] Bispebjerg & Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark
[2] North Zealand Hosp, Dept Cardiol, Hillerod, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[4] Herlev Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark
关键词
cardiac implantable electronic device; cardiac tamponade; clinically relevant pericardial effusion; pericardiocentesis; postprocedural complication; ANTIPLATELET THERAPY; PACEMAKER; COMPLICATIONS; PERFORATION; PREDICTORS; ANTICOAGULATION; AMYLOIDOSIS; MANAGEMENT; HEPARIN;
D O I
10.1111/jce.16442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pericardial effusion, a known complication to implantation of cardiac implantable electronic devices (CIED), may cause life-threatening cardiac tamponade. Limited knowledge is available about risk factors for clinically relevant procedural pericardial effusion. The aim is to identify the patient- and procedure-related risk factors associated with clinically relevant procedural pericardial effusion. Method: A nationwide observational cohort study based on data on 55 121 patients from the Danish Pacemaker Register between 2000 and 2018. We defined a clinically relevant procedural pericardial effusion related to the implantation if it occurred within 90 days after the primary CIED-procedure. Prespecified risk factors were analysed by multivariable logistic regression models to estimate the association with pericardial effusion. Results: There were 115 (0.21%) patients diagnosed with clinically relevant procedural pericardial effusion, with a median age of 75 years and 38.3% were females. Of these, 80.9% lead to a subsequent pericardiocentesis procedure. In adjusted logistic regression analysis, an increased risk of clinically relevant pericardial effusion was associated with female sex (OR:1.49 [95%CI: 1.03-2.16]), heart failure (OR:1.54 [95%CI: 1.06-2.23]), previous cardiac surgery (OR:1.63 [95%CI: 1.05-2.55]), CRT-device (OR:2.05 [95%CI: 1.23-3.41]), tertiary-centres (OR:1.8 [95%CI: 1.18-2.73]), increased procedural volume per year (>1000) (OR:1.85 [95%CI: 1.03-3.30]), indication of device-implantation (atrioventricular block) (OR:2.37 [95CI: 1.45-3.87]), and increasing number of leads implanted (two leads (OR:2.39 [95%CI: 1.43-4.00]), three leads (OR:4.77 [95%CI: 2.50-9.10])). Conclusion: Clinically relevant procedural pericardial effusion is a rare complication after CIED-implantation in Denmark. This study reveals important patient- and procedure-related risk factors associated with clinically relevant procedural pericardial effusion.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Cardiovascular implantable electronic device infections: associated risk factors and prevention
    Rohacek, Martin
    Baddour, Larry M.
    SWISS MEDICAL WEEKLY, 2015, 145
  • [22] Impact of Immunosuppressive Therapy on Lead Dislodgement After Cardiac Implantable Electronic Device Implantation
    Matsuda, Yasuhiro
    Masuda, Masaharu
    Asai, Mitsutoshi
    Okamoto, Shin
    Ishihara, Takayuki
    Nanto, Kiyonori
    Tsujimura, Takuya
    Hata, Yosuke
    Uematsu, Hiroyuki
    Higashino, Naoko
    Nakao, Sho
    Kusuda, Masaya
    Mano, Toshiaki
    CLINICAL CARDIOLOGY, 2024, 47 (06)
  • [23] Factors associated with early and late Staphylococcus aureus bacteraemia after first cardiac implantable electronic device implantation a Danish nationwide cohort study
    Bengtsen, K.
    Falkentoft, A. C.
    Haji, H.
    Haugan, K.
    Philbert, B. T.
    Johansen, J. B.
    Torp-Pedersen, C.
    Riahi, S.
    Nielsen, J. C.
    Larroude, C.
    Petersen, A.
    Larsen, A. R.
    Fosboel, E. L.
    Bruun, N. E.
    Ruwald, A. C.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [24] Anticoagulation for patients undergoing implantation of a cardiac implantable electronic device
    Llewellyn, Jennifer
    Ezeonwumelu, Chinenyenwa
    Jackson, Lynsey
    Rao, Archana
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (12)
  • [25] Risk Factors of Haematoma Formation Following Cardiac Implantable Electronic Device Procedures
    Wang, Benjamen
    Yao, Jessica
    Sethwala, Anver
    Hawson, Joshua
    Stevenson, Irene
    HEART LUNG AND CIRCULATION, 2022, 31 (11): : 1539 - 1546
  • [26] Pericardial Effusion After Cardiac Surgery: Risk Factors, Patient Profiles, and Contemporary Management
    Ashikhmina, Elena A.
    Schaff, Hartzell V.
    Sinak, Lawrence J.
    Li, Zhuo
    Dearani, Joseph A.
    Suri, Rakesh M.
    Park, Soon J.
    Orszulak, Thomas A.
    Sundt, Thoralf M., III
    ANNALS OF THORACIC SURGERY, 2010, 89 (01): : 112 - 118
  • [27] PREVALENCE AND RISK FACTORS FOR PERICARDIAL EFFUSION REQUIRING READMISSION AFTER PEDIATRIC CARDIAC SURGERY
    Elias, Matthew D.
    Glatz, Andrew C.
    O'Connor, Matthew J.
    Schachtner, Susan
    Ravishankar, Chitra
    Mascio, Christopher E.
    Cohen, Meryl S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 979 - 979
  • [28] Risk factors for cardiac implantable electronic device infections: a nationwide Danish study
    Olsen, Thomas
    Jorgensen, Ole Dan
    Nielsen, Jens Cosedis
    Thogersen, Anna Margrethe
    Philbert, Berit Thornvig
    Frausing, Maria Hee Jung Park
    Sandgaard, Niels Christian Foldager
    Johansen, Jens Brock
    EUROPEAN HEART JOURNAL, 2022, 43 (47) : 4946 - +
  • [29] Clinical factors associated with persistent pericardial effusion after successful primary coronary angioplasty
    Sugiura, T
    Nakamura, S
    Kudo, Y
    Okumiya, T
    Yamasaki, F
    Iwasaka, T
    CHEST, 2005, 128 (02) : 798 - 803
  • [30] Risk of infection and vascular complications with cardiac implantable electronic device implantation in patients with a history of mastectomy
    Yeo, Yong Hao
    San, Boon Jian
    Tan, Jia Yi
    Jaiyesimi, Ishmael
    Mehta, Nishaki
    HEART RHYTHM, 2024, 21 (10) : 2058 - 2059